Group One Trading »

Lineage Cell Therapeutics In call shares owned by Group One Trading

Quarter-by-quarter ownership of Lineage Cell Therapeutics In call shares owned by Group One Trading from 13F filings

Historical chart of Group One Trading investment in Lineage Cell Therapeutics In call

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In call held by Group One Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In call by Group One Trading

Quarter filed Position value Share count Share price at filing
2025-09-30 $173k 102k 1.69
2025-06-30 $253k 279k 0.91
2025-03-31 $81k 179k 0.45
2024-12-31 $26k 52k 0.50
2024-06-30 $67k 68k 1.00
2024-03-31 $215k 146k 1.48
2023-09-30 $28k 24k 1.18
2023-06-30 $44k 32k 1.41
2023-03-31 $7.4k 4.9k 1.50
2022-12-31 $20k 17k 1.17
2022-09-30 $54k 48k 1.12
2022-03-31 $108k 70k 1.54
2021-12-31 $277k 113k 2.45
2021-09-30 $150k 60k 2.52
2021-06-30 $211k 74k 2.85
2021-03-31 $260k 111k 2.35
2020-12-31 $331k 188k 1.76
2020-09-30 $14k 15k 0.93
2020-06-30 $30k 34k 0.88
2020-03-31 $25k 30k 0.83
2019-09-30 $1.0k 1.5k 0.67

Top funds holding Lineage Cell Therapeutics In call